KSE - Delayed Quote KRW

JW Holdings Corporation (096760.KS)

2,980.00 -30.00 (-1.00%)
At close: April 26 at 3:30 PM GMT+9
Key Events
Loading Chart for 096760.KS
DELL
  • Previous Close 3,010.00
  • Open 3,045.00
  • Bid --
  • Ask --
  • Day's Range 2,900.00 - 3,045.00
  • 52 Week Range 2,880.00 - 4,397.06
  • Volume 545,645
  • Avg. Volume 68,201
  • Market Cap (intraday) 215.323B
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 8, 2024 - May 13, 2024
  • Forward Dividend & Yield 105.00 (3.52%)
  • Ex-Dividend Date Dec 27, 2023
  • 1y Target Est --

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea and internationally. It offers IV solutions; non-PVC films, tube, and empty bags; carbapenem, specialized, and ETC drugs; and APIs. The company also provides medical devices, such as infant care systems, OB/GY examining tables, operating tables, operating lights, steam sterilizers, as well as other equipment, including scrub stations and suction units; and wound, pain, and beauty care products. JW Holdings Corporation was founded in 1945 and is based in Gwacheon-si, South Korea.

www.jw-holdings.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 096760.KS

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

096760.KS
14.61%
KOSPI Composite Index
0.04%

1-Year Return

096760.KS
1.21%
KOSPI Composite Index
6.90%

3-Year Return

096760.KS
29.00%
KOSPI Composite Index
17.44%

5-Year Return

096760.KS
42.84%
KOSPI Composite Index
21.89%

Compare To: 096760.KS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 096760.KS

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    215.32B

  • Enterprise Value

    615.41B

  • Trailing P/E

    11.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.23

  • Price/Book (mrq)

    1.74

  • Enterprise Value/Revenue

    0.66

  • Enterprise Value/EBITDA

    4.73

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.05%

  • Return on Assets (ttm)

    7.69%

  • Return on Equity (ttm)

    9.10%

  • Revenue (ttm)

    928.07B

  • Net Income Avi to Common (ttm)

    19.03B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    154.5B

  • Total Debt/Equity (mrq)

    159.02%

  • Levered Free Cash Flow (ttm)

    11.94B

Company Insights: 096760.KS

People Also Watch